Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
05/2005
05/19/2005US20050106161 Vaccine ; human leukemia, lymphoma virus
05/19/2005US20050106160 Hiv-1 envelope glycoproteins stabilized by flexible linkers as potent entry inhibitors and immunogens
05/19/2005US20050106157 Immunogenic formulations comprising oil bodies
05/19/2005US20050106154 GASP1: a follistatin domain containing protein
05/19/2005US20050106152 Using protein antagonist; amino acid sequence; antisense nucleotide; inducing apoptosis
05/19/2005US20050106148 Method of treating blood disorders
05/19/2005US20050106146 Protein that controlles gastrointestinal system; therapy for nutritional homeostasis
05/19/2005US20050106143 Collapsin response mediator protein; measurement of gene expression
05/19/2005US20050106141 Hairless protein-interacting partner complexes and methods thereof for the beautification and/or improvement of mammalian skin
05/19/2005US20050106135 Compositions, kits and treating methods for alteration cell-cell adhesion, transport, or permeation properties of tissues
05/19/2005US20050106124 Therapeutic applications of thrombomodulin gene via viral and non-viral vectors
05/19/2005US20050106123 Using primers; heterogeneity genetic engineered adenovirus or poxviruse vectors
05/19/2005US20050106105 Complex of annexin and ultrasonic contrast particles or polymer
05/19/2005US20050106102 Avidin dimers effective in increasing the concentration of radioactive biotin in pretargeted radioimmunotherapy
05/19/2005US20050106099 Fusion proteins
05/19/2005DE10164819A1 Verfahren zur Identifizierung von Zielepitopen der T-Zell-vermittelten Immunantwort und zum Nachweis Epitop-spezifischer T-Zellen A method for identifying target epitopes of the T-cell mediated immune response and for the detection of epitope-specific T-cells
05/19/2005CA2830063A1 Stabilized alpha helical peptides and uses thereof
05/19/2005CA2586320A1 Bonding tissues and cross-linking proteins with naphthalimide compounds
05/19/2005CA2548538A1 Compositions and methods of use for a fibroblast growth factor
05/19/2005CA2545160A1 Variants of human glycoprotein hormone alpha chain: compositions and uses thereof
05/19/2005CA2544848A1 Method of preventing virus: cell fusion by inhibiting the function of the fusion initiation region in rna viruses having class i membrane fusogenic envelope proteins
05/19/2005CA2544821A1 Simian orl1 gene and method of assessing compound
05/19/2005CA2544807A1 Compositions and methods of using apoptosis signaling kinase related kinase (askrk)
05/19/2005CA2544764A1 Protein binding miniature proteins
05/19/2005CA2544223A1 Stabilized alpha helical peptides and uses thereof
05/19/2005CA2544214A1 Hla-dr-binding antigen peptide derived from wt1
05/19/2005CA2543866A1 Protozoan strains of reduced virulence and use thereof
05/19/2005CA2543837A1 Bace455, an alternative splice variant of the human beta-secretase
05/19/2005CA2543719A1 Methods and compositions for modulating apoptosis
05/19/2005CA2542018A1 Radioactive multiplexing analytical methods
05/19/2005CA2538005A1 Method for preparing polyfunctionalized peptides and/or proteins via native chemical ligation
05/19/2005CA2537759A1 Monomeric recombinant mhc molecules useful for manipulation of antigen-specific t cells
05/18/2005EP1531168A1 Process for the removal of porogens from temperature sensitive macroreticular polymers using steam at reduced pressure
05/18/2005EP1531161A2 Human epidermal proteins HEPI-1 to HEPI-6
05/18/2005EP1531160A1 Recovery of a heat shock protein
05/18/2005EP1530973A2 Methods for inducing T cell tolerance to a tissue or organ graft
05/18/2005EP1530725A1 Materials and methods for inductions of immune tolerance
05/18/2005EP1530645A2 Method of identifying genes involved in cell growth regulation
05/18/2005EP1530642A2 Use of lactobacillus to produce exopolysaccharides in food and pharmaceutical compositions
05/18/2005EP1530639A2 Gene and polypeptide sequences
05/18/2005EP1530638A2 T-cell epitopes in staphylococcal enterotoxin b
05/18/2005EP1530632A2 Growth factor which acts through erb b-4 rtk
05/18/2005EP1530629A2 Variants of antithrombin iii
05/18/2005EP1530592A1 Chimeric mhc protein and oligomer thereof
05/18/2005EP1530591A2 Nuclear hormone receptor ligand-binding domain containing protein
05/18/2005EP1530590A2 Triggering receptors expressed on myeloid cells (trem)-4 and -5 and uses thereof
05/18/2005EP1530589A2 Fragments of proinsulin c-peptide
05/18/2005EP1530588A2 Long lasting natriuretic peptide derivatives
05/18/2005EP1530587A1 Il-8 like protein
05/18/2005EP1530586A2 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
05/18/2005EP1530584A2 Synthetic or natural peptides binding protein phosphatase 2a, identification method and uses
05/18/2005EP1530583A2 Novel calpastatin (cast) alleles
05/18/2005EP1530582A2 Diagnosis of kidney damage and protection against same
05/18/2005EP1530483A2 T cell receptor cdr3 sequences and methods for detection
05/18/2005EP1432805B1 Dna-expression construct for treatment of infections with leishmaniasis
05/18/2005EP1397035A4 Method for modifying a plant phenotype
05/18/2005EP1214402B1 Plant regulatory sequences for selective control of gene expression
05/18/2005EP1212442B1 Enhanced plant cell transformation by addition of host genes involved in t-dna integration
05/18/2005EP1161530B1 Protein for blocking platelet adhesion
05/18/2005EP1145011B1 Compositions and methods for the diagnosis and treatment of tumor
05/18/2005EP1034185B1 Pharmaceutical compositions containing the long pentraxin ptx3
05/18/2005EP0970187B1 Pituitary differentiation factor and methods of use thereof
05/18/2005EP0894141B1 Hybrid proteins which form heterodimers
05/18/2005EP0868523B1 Vector for expression of n-terminally extended proteins in yeast cell
05/18/2005EP0845040B1 Plastid inner envelope membrane targeting polypeptides; manufacture and use thereof
05/18/2005EP0830138B1 Use of fibroblast growth factor analogues to stimulate bone growth
05/18/2005EP0662137B1 Gene transcription and ionizing radiation: methods and compositions
05/18/2005EP0584348B1 Genetic vaccine for immunodeficiency viruses
05/18/2005CN1617938A Method for isolating nucleic acids and protein from a single sample
05/18/2005CN1617887A Corticotropin releasing factor receptor 2 agonists
05/18/2005CN1617886A Corticotropin releasing factor receptor 2 agonists
05/18/2005CN1617885A Corticotropin releasing factor receptor 2 agonists
05/18/2005CN1617884A Beta-amyloid binding factors and inhibitors thereof
05/18/2005CN1617881A Chemical process
05/18/2005CN1617740A Immunisation against chlamydia trachomatis
05/18/2005CN1617732A Nuclear-envelope and nuclear-lamina binding chimeras for modulating gene expression
05/18/2005CN1617673A Enhanced oil seed protein recovery
05/18/2005CN1616670A 感染性克隆 Infectious clone
05/18/2005CN1616664A Transgenic plants with altered senescence characteristics
05/18/2005CN1616661A Modulator of TNF/NGF superfamily receptors and soluble oligomeric TNF/NGF superfamily receptors
05/18/2005CN1616489A Method for purifying and recombining human iterleukin-12
05/18/2005CN1616488A Primary structure of Anjikang protein of snake soure desintegration mutant anti-tumor medicine
05/18/2005CN1616487A Liver cancer apoptosis inducing factor and its encoding gene and use
05/18/2005CN1616486A Pseudomonas pseudoalcaligenes disinsection protein gene
05/18/2005CN1616485A SARS coronavirus structure protein ORF3 and its use
05/18/2005CN1616483A A group of artificially synthetic antibacterial peptide and its preparing method and use
05/18/2005CN1616482A Synthetic Method for propoxur artificial antigen
05/18/2005CN1616481A Synthetic method for metolcarb artificial antigen
05/18/2005CN1616478A Expression of P27 protein and its use
05/18/2005CN1616432A Compound, its use and pharmaceutical compositions comprising same
05/18/2005CN1616084A Botulinum toxin pharmaceutical compositions
05/18/2005CN1202257C Recombination carrier and treating composition used in insulin dependent diabetes gene curing
05/18/2005CN1202256C Regulatory sequences useful for gene expression in plant embryo tissue
05/18/2005CN1202252C Recombination proteins of Pakistani strain of hepatitis E and their use in diagnostic method and vaccines
05/18/2005CN1202250C Chinese cabbage BcpFLC3 protein nucleotide sequence
05/18/2005CN1202247C Chimeric heteromultimer adhesins
05/18/2005CN1202244C Protein having aspartase activity and gene DNA coding for the same
05/18/2005CN1202131C Technology of one kettle method for liquid phase synthesizing thymopentapeptide
05/18/2005CN1202130C Solid, stable and concentrated type ortho-silicis acid complex based on bio-absorption, and its prepn. method
05/18/2005CN1202129C GDNF mutant and its medical application
1 ... 1215 1216 1217 1218 1219 1220 1221 1222 1223 1224 1225 1226 1227 1228 1229 1230 1231 1232 1233 1234 1235 ... 2916